Literature DB >> 21274081

Hypodermoclysis for symptom control in terminal care.

H Hays.   

Abstract

Subcutaneous infusions of fluid and electrolytes can be used for replacement and correction of imbalance, by a method known as hypodermoclysis (HDC). Since April 1982, the Palliative Care Unit of the Edmonton General Hospital has been using this method for symptom control, titrating the rate of infusion against the severity of the symptoms, when the oral route was no longer available. If incompatible drugs have to be given at the same time, or if two drugs have to be given at different rates, two sites are used simultaneously. HDC is an adequate method of symptom control for terminal patients; it has advantages over intravenous, intermittent subcutaneous or intramuscular routes and rectal infusion, when used as described.

Entities:  

Year:  1985        PMID: 21274081      PMCID: PMC2327561     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  13 in total

1.  ANAPHYLACTOID reactions to penicillin.

Authors: 
Journal:  N Engl J Med       Date:  1953-12-10       Impact factor: 91.245

2.  Clinical uses of hyaluronidase; a current review.

Authors:  R C BRITTON; D V HABIF
Journal:  Surgery       Date:  1953-06       Impact factor: 3.982

3.  Hyaluronidase and the subcutaneous administration of electrolyte-free glucose solution.

Authors:  F M MATEER; K L GARVER; M J SAKOL; T S DANOWSKI
Journal:  Am J Med Sci       Date:  1953-08       Impact factor: 2.378

4.  BIOCHEMICAL AND HEMODYNAMIC CHANGES FOLLOWING THE SUBCUTANEOUS INJECTION OF GLUCOSE SOLUTION.

Authors:  T S Danowski; A W Winkler; J R Elkinton
Journal:  J Clin Invest       Date:  1947-09       Impact factor: 14.808

5.  Hyaluronidase in paediatric therapy.

Authors:  W GAISFORD; D G EVANS
Journal:  Lancet       Date:  1949-09-17       Impact factor: 79.321

6.  The danger of administering parenteral fluids by hypodermoclysis.

Authors:  W E ABBOTT; S LEVEY; R C FOREMAN; H KRIEGER; W D HOLDEN
Journal:  Surgery       Date:  1952-08       Impact factor: 3.982

7.  Hyaluronidase; further evaluation in pediatrics.

Authors:  J SCHWARTZMAN; M LEVBARG
Journal:  J Pediatr       Date:  1950-01       Impact factor: 4.406

8.  Hyaluronidase in geriatric therapy.

Authors:  R G Simpson
Journal:  Practitioner       Date:  1977-09

9.  Complications of hypodermoclysis (re-emphasis with a case presentation).

Authors:  B D Hall
Journal:  J Ky Med Assoc       Date:  1968-07

10.  Nutrition by hypodermoclysis.

Authors:  E Y Berger
Journal:  J Am Geriatr Soc       Date:  1984-03       Impact factor: 5.562

View more
  1 in total

1.  Hypodermoclysis and system management.

Authors:  H Hays
Journal:  Can Fam Physician       Date:  1993-02       Impact factor: 3.275

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.